Australia markets open in 2 hours 31 minutes
  • ALL ORDS

    7,398.90
    +7.90 (+0.11%)
     
  • AUD/USD

    0.7110
    +0.0074 (+1.05%)
     
  • ASX 200

    7,148.90
    +3.30 (+0.05%)
     
  • OIL

    110.59
    +0.31 (+0.28%)
     
  • GOLD

    1,852.10
    +10.00 (+0.54%)
     
  • BTC-AUD

    41,350.49
    -1,080.96 (-2.55%)
     
  • CMC Crypto 200

    658.56
    -16.31 (-2.42%)
     

Is AbbVie Stock a Top Pick for 2022?

·4-min read
Is AbbVie Stock a Top Pick for 2022?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Treasury yields are rising, and the Federal Reserve is expected to raise interest rates multiple times in 2022. In the case of AbbVie (NYSE: ABBV), look no further. AbbVie is a global prescription drug developer, manufacturer, and distributor that was spun off from parent company Abbott Labs back in 2013.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting